ISCA2 and nonpapillary renal cell carcinoma: Thus, the data suggest that low ISCA2 levels in ccRCC are associated with pVHL loss and with poorer prognosis, and that cells lacking functional pVHL are more sensitive to ISCA2 inhibition, in part due to decreased ISCA2.